Uwe Haberkorn
Overview
Explore the profile of Uwe Haberkorn including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
442
Citations
15924
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mori Y, Tamburini K, Novruzov E, Schmitt D, Mavriopoulou E, Loosen S, et al.
Ann Nucl Med
. 2025 Mar;
PMID: 40048016
Introduction: Liver fibrosis is a chronic fibrosing hepatic disorder following recurrent injury, characterized by the excessive accumulation of extracellular matrix. Early detection has a great clinical impact because 80-90% of...
2.
McGale J, Khurana S, Howell H, Nakhla A, Roa T, Doshi P, et al.
Clin Nucl Med
. 2025 Jan;
50(3):e138-e145.
PMID: 39780367
Breast cancer presents a significant global health challenge, necessitating continued innovation in diagnostic and therapeutic approaches. Recent advances have led to the identification of cancer-associated fibroblasts, which are highly prevalent...
3.
Farid K, Bug G, Schmitt A, Lang F, Schubert M, Haberkorn U, et al.
Front Immunol
. 2024 Dec;
15:1500177.
PMID: 39624098
Introduction: CAR T-cell therapy is highly effective, but also associated with unique toxicities. Because of the origin of T cells in patients who previously underwent allogeneic hematopoietic cell transplantation (alloHCT),...
4.
Hope T, Calais J, Goenka A, Haberkorn U, Konijnenberg M, McConathy J, et al.
J Nucl Med
. 2024 Nov;
66(1):26-33.
PMID: 39572227
No abstract available.
5.
Glemser P, Freitag M, Kovacs B, Netzer N, Dimitrakopoulou-Strauss A, Haberkorn U, et al.
EJNMMI Rep
. 2024 Nov;
8(1):37.
PMID: 39510993
Background: To investigate the ability of artificial intelligence (AI)-based and semi-quantitative dynamic contrast enhanced (DCE) multiparametric MRI (mpMRI), performed within [F]-PSMA-1007 PET/MRI, in differentiating benign from malignant prostate tissues in...
6.
Werner J, Umstatter F, Bohmann M, Muller H, Beijer B, Hertlein T, et al.
Adv Sci (Weinh)
. 2024 Nov;
11(48):e2411406.
PMID: 39499737
Antibiotic-resistant enterococci represent a significant global health challenge. Unfortunately, most β-lactam antibiotics are not applicable for enterococcal infections due to intrinsic resistance. To extend their antimicrobial spectrum, polycationic peptides are...
7.
Helisch A, Kratochwil C, Kleist C, Kramer S, Rosales Castillo J, Dendl K, et al.
J Nucl Med
. 2024 Oct;
65(12):1917-1922.
PMID: 39477492
Radiopharmaceutical therapies (RPTs) based on fibroblast activation protein (FAP) and FAP inhibitors (FAPIs) are a new option for progressive metastatic cancer in patients pretreated multiple times. To date, published in-human...
8.
Broker-Lai J, Rego Terol J, Richter C, Mathar I, Wirth A, Kopf S, et al.
EMBO J
. 2024 Oct;
43(23):5813-5836.
PMID: 39375537
Hypoglycemia triggers autonomic and endocrine counter-regulatory responses to restore glucose homeostasis, a response that is impaired in patients with diabetes and its long-term complication hypoglycemia-associated autonomic failure (HAAF). We show...
9.
Weykamp F, Schaub L, Eichhorn M, Winter H, Schirmacher P, Thomas M, et al.
Adv Radiat Oncol
. 2024 Sep;
9(9):101573.
PMID: 39234234
Purpose: Superior sulcus tumors are frequently treated with neoadjuvant chemoradiation therapy (nCRT) followed by surgery via a trimodal approach. The INKA study evaluated the replacement of photon irradiation by carbon...
10.
Bengel F, Epstein J, Gropler R, Haberkorn U, Kramann R, Lavine K, et al.
Nat Cardiovasc Res
. 2024 Aug;
3(4):414-419.
PMID: 39196217
No abstract available.